Earlier this year we gave a strong buy signal on Eli Lilly and Company (LLY) on March 01 (see chart below) where we called for the most optimal buy entry exactly at the bottom of the bullish pattern: The price has now hit (last week) the top of the 4 year logarithmic Channel Up, highly overbought with the RSI on the 1W time-frame reaching 84.30, breaking...
Looking through charts, CVAC caught my eye for some potential trade opportunities. Firstly lets look at the candle close of Today 08/01/23 -> We are currently testing this RED Resistance Arrow Line pointing down -> The candle has a lower wick, indicating some buying pressure ->However, the candle body is small, which may indicate waning momentum **If price...
Ive been eyeing TDOC for some time, finally posting a chart on it talking about TA developments that may indicate a potential bottom area earlier this week (Check below for the link to that chart). I was also in the camp of TDOC going lower to the low $20 or high Teens ($18-19). This weeks move of 30%, closing the weekly candle at 20% gains was a wonderful...
AbbVie Inc. (ABBV) opened today much higher than the 1D MA200 (orange trend-line), which is a strong enough buy signal on its own. Coupled however with the fact that the rebound was achieved on the Higher Lows trend-line that started way back on the COVID (March 23 2020) market bottom, it makes it an even stronger one. In fact on a 2-3 month basis, this is the...
Welcome to the BasicTrading channel. My name is Philip and in todays analysis I quickly go over the situation which we currently have on UnitedHealth Group. I will analyse the asset both from a weekly and daily timeframe to show you the best possible trading opportunities. If you enjoyed this analysis, let me know in the comment section which asset I should...
Humana Inc. ( NYSE:HUM ) Sector: Health Services (Managed Health Care) Market Capitalization: 64.611B Current Price: $510.54 Breakout price trigger: $515.20 Buy Zone (Top/Bottom Range): $496.45-$473.95 Price Target: $562.30-$568.90 Estimated Duration to Target: 147-156d Contract of Interest: $HUM 1/20/23 520c Trade price as of publish date: $26.20/contract
AMN Healthcare Services Inc. ( NYSE:AMN ) Sector: Commercial Services (Personnel Services) Market Capitalization: $5.130B Current Price: $114.73 Breakout price: $115.20 Buy Zone (Top/Bottom Range): $113.95-$108.40 Price Target: $120.90-$123.70 Estimated Duration to Target: 38-40d Contract of Interest: $AMN 8/19/22 110c Trade price as of publish date: $10.80/contract
Technical Analysis : We broke the downtrend line and had three white soldiers to confirm the reversal of the trend, also the falling wedge shows a bullish reversal since we broke it upwards. Although on a lower timeframe MACD and RSI look bearish, we expect the price to reach our Buy Zone before the impulsive move upwards. Aroon : Aroon Up on Top and Aroon Down...
Downtrend Will Horizontal Price Movement within 1974-2101 can buy when drop near to support level . MYX:HEALTH
They have marked the supports and resistances of ALNOV. It has great upside potential, key level reaching $ 5 Last Friday news Clinical diagnostics specialist Novacyt announced on Friday thatots ‘genesig’ Covid-19 real-time PCR test has been approved in the UK. I send you a cordial greeting, Merry Christmas and a prosperous 2022 In Spain on 12/23/2021
Large Southwestern Health System Signs New Contract for Streamline Health® eValuator™ $STRM today announced it has signed a contract with a 1,300-bed, Epic EMR-based health system in Arizona. The healthcare provider will use eValuator’s cloud-based automated pre- and post-bill coding analysis technology to help improve revenue integrity for their inpatient and...
Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan® today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational Device Exemption (IDE) application, permitting Check-Cap to begin a pivotal study of C-Scan in the U.S. The pivotal study will evaluate safety and performance of C-Scan as well as subject...
Exela Technologies Wins $90 Million Contract for Cloud-Hosted PCH Global, Delivering Healthcare Solutions for Major US Insurer $XELA today announced a 10 year, $90 million venture blending automation technologies, SaaS, and services through its PCH Global platform, which officially launched in September of last year. This effort will accelerate the digital...
Tangible catalyst behind surge is due to the upcoming launch of Truforma , Zomedica’s point-of-care (POC) diagnostic device for the detection of thyroid disease in dogs and cats and adrenal disease in dogs. The platform will hit the market on March 30 , and ahead of the product’s debut, the company has also just nabbed a vital distribution deal. Last week,...
Day Traders Lighting Up Reddit Spur Rally in Tiny Health Stock Zomedica Such outsized moves in small-caps are becoming par for the course these days. Surging at the open on the back of mentions in Reddit forums was Zomedica Corp., a company that develops medicines for pets. The stock jumped as much as 98% on Monday and is up almost four-fold from the start or...
$GRST: AFTER A SUCCESSFUL BREAKOUT FROM THE CUP AND HANDLE FORMATION ABOVE .003/.0042, $GRST REACHED HIGHS NEARING THE PSYCHOLOGICAL LEVEL OF .01, AND LEVELED OFF TO RETEST THE UPTREND AND FOUND SOLID SUPPORT AT THE BREAKOUT LEVELS FROM THE PREVIOUS FORMATION. WE ARE NOW SWINGING BACK TO RETEST THE PENNY LEVEL, AND WHEN BROKEN THIS TIME AROUND WE SHOULD SEE A...
With the Covid-19 situation, the health technology sector is clearly going to benefit in the short, medium and long term. I can clearly a trend from the last 3 weeks.
NVS was among the high cap losers yesterday on the renewed coronavirus tensions and pulled back dramatically (-6.90%). This however can be the buy opportunity of the next several months as it hit the 1D MA200 (orange line) and is approaching the Higher Low trend line of the 1W Channel Up (RSI = 45.378, MACD = 1.640, ADX = 65.865). Even though the MACD indicated...